(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -1.95%2.67B | 12.39%11.54B | 15.64%8.56B | 21.70%5.64B | 29.53%2.72B | 37.92%10.27B | 39.63%7.4B | 41.06%4.63B | 41.19%2.1B | 45.00%7.44B |
Operating income | -1.95%2.67B | 12.39%11.54B | 15.64%8.56B | 21.70%5.64B | 29.53%2.72B | 37.92%10.27B | 39.63%7.4B | 41.06%4.63B | 41.19%2.1B | 45.00%7.44B |
Cost of sales | ---- | -14.21%-7.44B | ---- | -19.24%-3.6B | ---- | -36.58%-6.52B | ---- | -44.17%-3.02B | ---- | -48.31%-4.77B |
Operating expenses | -2.84%-1.8B | -14.21%-7.44B | -16.60%-5.48B | -19.24%-3.6B | -24.28%-1.75B | -36.58%-6.52B | -39.81%-4.7B | -44.17%-3.02B | -44.77%-1.41B | -48.31%-4.77B |
Gross profit | -10.55%872.15M | 9.22%4.09B | 13.95%3.08B | 26.31%2.04B | 40.16%974.97M | 40.31%3.75B | 39.34%2.7B | 35.59%1.61B | 34.47%695.63M | 39.45%2.67B |
Selling expenses | 0.41%-55.47M | -9.87%-252.78M | -18.94%-193.92M | -17.27%-126.78M | -18.95%-55.7M | -47.84%-230.07M | -56.20%-163.04M | -69.63%-108.11M | -46.04%-46.82M | -67.97%-155.62M |
Administrative expenses | 3.81%-398.61M | -7.75%-1.67B | -17.15%-1.21B | -27.89%-845.44M | -42.63%-414.38M | -70.85%-1.55B | -73.19%-1.04B | -72.34%-661.07M | -54.23%-290.52M | -32.64%-908.21M |
Research and development expenses | -21.82%-93.61M | -58.78%-448.28M | -67.22%-296.76M | -117.74%-182.18M | -93.81%-76.84M | -86.02%-282.33M | -61.55%-177.47M | -29.79%-83.67M | -36.27%-39.65M | -44.07%-151.78M |
Profit from asset sales | -17,640.70%-20M | ---- | 118.51%248.31K | ---- | 124.01%114K | ---- | -17.65%-1.34M | ---- | -9.79%-474.7K | ---- |
Revaluation surplus | -103.94%-1.13M | ---- | -48.12%40.2M | ---- | -36.42%28.58M | ---- | 328.45%77.49M | ---- | 205.59%44.96M | ---- |
-Changes in the fair value of other assets | -103.94%-1.13M | ---- | -48.12%40.2M | ---- | -36.42%28.58M | ---- | 328.45%77.49M | ---- | 205.59%44.96M | ---- |
Impairment and provision | -48.33%-6.47M | -69.33%-35.83M | -95.17%-23.61M | -69.00%-10.71M | -1,025.65%-4.36M | -106.03%-21.16M | -82.15%-12.1M | -1,443.01%-6.34M | 82.86%-387.47K | 30.72%-10.27M |
-Other impairment is provision | -48.33%-6.47M | -69.33%-35.83M | -95.17%-23.61M | -69.00%-10.71M | -1,025.65%-4.36M | -106.03%-21.16M | -82.15%-12.1M | -1,443.01%-6.34M | 82.86%-387.47K | 30.72%-10.27M |
Operating interest expense | ---- | ---- | ---- | -9.60%-89.03M | ---- | ---- | ---- | -414.60%-81.24M | ---- | ---83.07M |
Special items of operating profit | 81.86%64.63M | 65.17%336.11M | 132.75%106.16M | 53.44%114.24M | 210.94%35.54M | -57.25%203.49M | -72.56%45.61M | 623.82%74.45M | -79.84%11.43M | 36.33%476.05M |
Operating profit | -29.53%331.85M | 8.28%2.02B | 3.79%1.44B | 20.13%897.54M | 30.70%470.91M | 1.54%1.87B | 13.73%1.38B | 11.03%747.14M | 33.25%360.3M | 34.46%1.84B |
Financing cost | -61.25%-63.44M | -8.89%-182.19M | 32.76%-108.84M | ---- | 2.22%-39.34M | ---167.31M | -1,282.67%-161.87M | ---- | -416.87%-40.23M | ---- |
Share of profits of associates | ---- | 93.84%-2.08M | ---- | 347.40%10.98M | ---- | -147.12%-33.85M | ---- | 36.52%-4.44M | ---- | 392.47%71.85M |
Special items of earning before tax | 104.11%204.32K | ---- | 51.46%-7.54M | ---- | -27.90%-4.97M | ---- | -349.98%-15.53M | ---- | -537.69%-3.89M | ---- |
Earning before tax | -37.03%268.62M | 10.29%1.84B | 9.40%1.32B | 22.33%908.53M | 34.92%426.6M | -12.80%1.67B | 0.41%1.21B | 11.53%742.7M | 11.93%316.18M | 44.84%1.91B |
Tax | 31.07%-52.7M | 18.50%-256.11M | 29.20%-186.42M | 29.84%-124.46M | 3.50%-76.45M | -8.02%-314.25M | -32.55%-263.29M | -49.56%-177.4M | -72.94%-79.23M | -68.77%-290.92M |
After-tax profit from continuing operations | -38.33%215.92M | 16.98%1.58B | 20.16%1.13B | 38.70%784.07M | 47.77%350.15M | -16.54%1.35B | -5.95%944.18M | 3.29%565.3M | 0.12%236.95M | 41.25%1.62B |
Earning after tax | -38.33%215.92M | 16.98%1.58B | 20.16%1.13B | 38.70%784.07M | 47.77%350.15M | -16.54%1.35B | -5.95%944.18M | 3.29%565.3M | 0.12%236.95M | 41.25%1.62B |
Minority profit | -873.86%-14.64M | 14.03%-19.32M | 73.33%-4.51M | 89.94%-2.03M | 115.59%1.89M | 45.14%-22.47M | 53.15%-16.93M | -14.80%-20.13M | -31.87%-12.13M | -61.29%-40.95M |
Profit attributable to shareholders | -33.80%230.56M | 16.48%1.6B | 18.51%1.14B | 34.28%786.09M | 39.81%348.26M | -17.24%1.37B | -7.59%961.11M | 3.65%585.43M | 1.31%249.09M | 41.68%1.66B |
Basic earnings per share | -33.94%0.13 | 16.55%0.9033 | 18.81%0.643 | 34.85%0.4442 | -6.42%0.1968 | -44.60%0.775 | -38.18%0.5412 | -30.67%0.3294 | -32.27%0.2103 | -5.65%1.3988 |
Diluted earnings per share | -34.01%0.1298 | 16.54%0.9019 | 18.75%0.6421 | 34.71%0.4436 | -6.29%0.1967 | -43.47%0.7739 | -38.11%0.5407 | -30.63%0.3293 | -32.20%0.2099 | -7.37%1.3691 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data